Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
17.85
-0.34 (-1.87%)
At close: Nov 2, 2026, 4:00 PM EST
18.01
+0.16 (0.88%)
After-hours: Nov 2, 2026, 7:30 PM EST

Arcus Biosciences Revenue

Arcus Biosciences had revenue of $41.00M in the quarter ending June 30, 2026, a decrease of -74.38%. This brings the company's total for the last twelve months to $117.00M, down -55.34% year-over-year. In the year 2025, Arcus Biosciences had annual revenue of $247.00M, down -4.26%. That makes Arcus Biosciences the 21,489th largest company in the world by revenue and 3,190th in the United States.

Revenue (ttm)
$117.00M
Revenue Growth
-55.34%
P/S Ratio
21.93
Revenue / Employee
$194,676
Employees
601
Market Cap
2.57B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025247.00M-11.00M-4.26%
Dec 31, 2024258.00M141.00M120.51%
Dec 31, 2023117.00M5.00M4.46%
Dec 31, 2022112.00M-271.00M-70.76%
Dec 31, 2021383.00M305.48M394.09%
Dec 31, 202077.52M62.52M416.78%
Dec 31, 201915.00M6.65M79.58%
Dec 31, 20188.35M6.94M491.15%
Dec 31, 20171.41M--
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.